ID

29225

Description

A Randomised Controlled Clinical Trial in Type 2 Diabetes Comparing Semaglutide to Placebo and Liraglutide; ODM derived from: https://clinicaltrials.gov/show/NCT00696657

Link

https://clinicaltrials.gov/show/NCT00696657

Keywords

Versions (1)
  1. 3/9/18 3/9/18 -
Copyright Holder

See clinicaltrials.gov

Uploaded on

March 9, 2018

DOI

To request one please log in.

License

Creative Commons BY 4.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Diabetes NCT00696657

English

Eligibility Diabetes NCT00696657

1 forms  
  1. StudyEvent: Eligibility
    1. Eligibility Diabetes NCT00696657
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
men and women-not-of-childbearing potential diagnosed with type 2 diabetes for at least three months
Description

Gender | Childbearing Potential Absent | Non-Insulin-Dependent Diabetes Mellitus Disease length

Data type

boolean

Alias
UMLS CUI [1]
C0079399
UMLS CUI [2,1]
C3831118
UMLS CUI [2,2]
C0332197
UMLS CUI [3,1]
C0011860
UMLS CUI [3,2]
C0872146
stable treatment regimen with either metformin (at least 1500 mg) or diet and exercise alone for at least three months
Description

Metformin Dose Stable | Diet therapy | Exercise

Data type

boolean

Alias
UMLS CUI [1,1]
C0025598
UMLS CUI [1,2]
C0178602
UMLS CUI [1,3]
C0205360
UMLS CUI [2]
C0012159
UMLS CUI [3]
C0015259
hba1c: 7.0-10.0 % (both inclusive)
Description

Glucohemoglobin measurement

Data type

boolean

Alias
UMLS CUI [1]
C0202054
body weight between 60 kg and 110 kg
Description

Body Weight

Data type

boolean

Alias
UMLS CUI [1]
C0005910
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
treatment with insulin, glp-1 receptor agonists (including liraglutide), dipeptidyl peptidase-4 inhibitors, sulphonylurea, thiazolidinediones, alpha-gis, or any investigational drug, within the last three months
Description

Insulin | GLP-1 Receptor Agonist | liraglutide | Dipeptidyl Peptidase 4 Inhibitors | Sulfonylurea | Thiazolidinediones | alpha-Glucosidase Inhibitors | Investigational New Drugs

Data type

boolean

Alias
UMLS CUI [1]
C0021641
UMLS CUI [2]
C2917359
UMLS CUI [3]
C1456408
UMLS CUI [4]
C2917254
UMLS CUI [5]
C0038766
UMLS CUI [6]
C1257987
UMLS CUI [7]
C1299007
UMLS CUI [8]
C0013230
impaired liver or kidney function
Description

Liver Dysfunction | Renal Insufficiency

Data type

boolean

Alias
UMLS CUI [1]
C0086565
UMLS CUI [2]
C1565489
proliferative retinopathy or maculopathy requiring acute treatment
Description

Proliferative retinopathy Treatment required for | Disorder of macula of retina Treatment required for

Data type

boolean

Alias
UMLS CUI [1,1]
C0339467
UMLS CUI [1,2]
C0332121
UMLS CUI [2,1]
C0730362
UMLS CUI [2,2]
C0332121
clinically significant active cardiovascular disease and uncontrolled treated/untreated hypertension
Description

Cardiovascular Disease | Uncontrolled hypertension Treated | Uncontrolled hypertension untreated

Data type

boolean

Alias
UMLS CUI [1]
C0007222
UMLS CUI [2,1]
C1868885
UMLS CUI [2,2]
C1522326
UMLS CUI [3,1]
C1868885
UMLS CUI [3,2]
C0332155
recurrent major hypoglycaemia or hypoglycaemic unawareness
Description

Recurrent severe hypoglycemia | Loss of hypoglycemic warning

Data type

boolean

Alias
UMLS CUI [1]
C0342316
UMLS CUI [2]
C0342317
present or planned use of any drug which could interfere with the glucose levels (e.g. systemic corticosteroids)
Description

Pharmaceutical Preparations Interfere with Glucose level | CORTICOSTEROIDS FOR SYSTEMIC USE

Data type

boolean

Alias
UMLS CUI [1,1]
C0013227
UMLS CUI [1,2]
C0521102
UMLS CUI [1,3]
C0428548
UMLS CUI [2]
C3653708
Back to the top of the page

Similar models

Eligibility Diabetes NCT00696657

1 forms
  1. StudyEvent: Eligibility
    1. Eligibility Diabetes NCT00696657
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
Gender | Childbearing Potential Absent | Non-Insulin-Dependent Diabetes Mellitus Disease length
Item
men and women-not-of-childbearing potential diagnosed with type 2 diabetes for at least three months
boolean
C0079399 (UMLS CUI [1])
C3831118 (UMLS CUI [2,1])
C0332197 (UMLS CUI [2,2])
C0011860 (UMLS CUI [3,1])
C0872146 (UMLS CUI [3,2])
Metformin Dose Stable | Diet therapy | Exercise
Item
stable treatment regimen with either metformin (at least 1500 mg) or diet and exercise alone for at least three months
boolean
C0025598 (UMLS CUI [1,1])
C0178602 (UMLS CUI [1,2])
C0205360 (UMLS CUI [1,3])
C0012159 (UMLS CUI [2])
C0015259 (UMLS CUI [3])
Glucohemoglobin measurement
Item
hba1c: 7.0-10.0 % (both inclusive)
boolean
C0202054 (UMLS CUI [1])
Body Weight
Item
body weight between 60 kg and 110 kg
boolean
C0005910 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Insulin | GLP-1 Receptor Agonist | liraglutide | Dipeptidyl Peptidase 4 Inhibitors | Sulfonylurea | Thiazolidinediones | alpha-Glucosidase Inhibitors | Investigational New Drugs
Item
treatment with insulin, glp-1 receptor agonists (including liraglutide), dipeptidyl peptidase-4 inhibitors, sulphonylurea, thiazolidinediones, alpha-gis, or any investigational drug, within the last three months
boolean
C0021641 (UMLS CUI [1])
C2917359 (UMLS CUI [2])
C1456408 (UMLS CUI [3])
C2917254 (UMLS CUI [4])
C0038766 (UMLS CUI [5])
C1257987 (UMLS CUI [6])
C1299007 (UMLS CUI [7])
C0013230 (UMLS CUI [8])
Liver Dysfunction | Renal Insufficiency
Item
impaired liver or kidney function
boolean
C0086565 (UMLS CUI [1])
C1565489 (UMLS CUI [2])
Proliferative retinopathy Treatment required for | Disorder of macula of retina Treatment required for
Item
proliferative retinopathy or maculopathy requiring acute treatment
boolean
C0339467 (UMLS CUI [1,1])
C0332121 (UMLS CUI [1,2])
C0730362 (UMLS CUI [2,1])
C0332121 (UMLS CUI [2,2])
Cardiovascular Disease | Uncontrolled hypertension Treated | Uncontrolled hypertension untreated
Item
clinically significant active cardiovascular disease and uncontrolled treated/untreated hypertension
boolean
C0007222 (UMLS CUI [1])
C1868885 (UMLS CUI [2,1])
C1522326 (UMLS CUI [2,2])
C1868885 (UMLS CUI [3,1])
C0332155 (UMLS CUI [3,2])
Recurrent severe hypoglycemia | Loss of hypoglycemic warning
Item
recurrent major hypoglycaemia or hypoglycaemic unawareness
boolean
C0342316 (UMLS CUI [1])
C0342317 (UMLS CUI [2])
Pharmaceutical Preparations Interfere with Glucose level | CORTICOSTEROIDS FOR SYSTEMIC USE
Item
present or planned use of any drug which could interfere with the glucose levels (e.g. systemic corticosteroids)
boolean
C0013227 (UMLS CUI [1,1])
C0521102 (UMLS CUI [1,2])
C0428548 (UMLS CUI [1,3])
C3653708 (UMLS CUI [2])
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial